The number of nuclear warheads maintained in the US stockpile, declared for the first time on the opening day of the United Nations nuclear non-proliferation conference in New York.
Source: Financial Times, 3 May
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oil Spill looMS laRgE US ecologists and coastal residents are preparing for an environmental catastrophe to unfold over the coming months as oil flowing from a ruptured pipeline into the Gulf of Mexico starts to lap at the Louisiana shore. As Nature went to press, an oil slick and oily sheen covering thousands of square kilometres (white swirl pictured) was being blown towards the fragile marshlands of the Mississippi delta, while the oil spewing into the ocean after the explosion and sinking of the Deepwater Horizon oil rig on 20 April showed no signs of abating or being brought under control by frantic engineers, with at least 800,000 litres erupting from the well every day. See go.nature.com/qzXUgX for more.
• poliCY Its first meeting will be on 14-15 May, and it plans to deliver a peer-reviewed report to the United Nations, who requested the review, by 30 August.
Overseas universities: India's government introduced a bill to its parliament on 3 May that would enable foreign universities to set up campuses in the country, in an effort to raise the quality of higher education. Overseas institutions would have to guarantee and maintain a fund of 500 million rupees (US$11 million), and plough all profits back into their Indian branch. The legislation is thought to be unlikely to pass until the next parliamentary session of India's lower house starts at the end of July. Cancer vaccine approved: A treatment for prostate cancer has become the first therapeutic cancer vaccine to receive regulatory approval in the United States. On 29 April, the US Food and Drug Administration (FDA) approved Provenge (sipuleucel-T) to treat advanced hormone-resistant prostate cancer. Stock in Dendreon, the vaccine's Seattle, Washingtonbased manufacturer, rose 27% on the announcement. Provenge seemed on the cusp of approval three years ago, but the FDA demanded additional clinical trial data (see Nature 464, 1110-1111; 2010). The vaccine is tailor-made from a patient's own immune cells, and will cost about $93,000 per patient, the company said.
Off-label marketing:
The drug giant AstraZeneca has agreed to pay US$520 million to settle US government allegations that it illegally promoted the anti-psychotic drug Seroquel (quetiapine fumarate) as Fund-raising success: The James Martin 21st Century School at the University of Oxford, UK, said on 28 April that it had secured US$100 million for new research in just one year. The institute met the challenge of its main benefactor, philanthropist and computer scientist James Martin, to find donors to match his $50-million conditional pledge. The money will be used for 19 research projects into 'global problems facing humanity' , such as the future of cities and vaccine design. Martin gave $100 million to establish the institute in 2005. a treatment for medical conditions for which it had not received approval -such as Alzheimer's disease, depression and sleeplessness. Under the terms of the agreement, disclosed last year but finalized on 27 April, the company continues to deny the allegations, which were first raised by the whistleblower James Wetta in 2004. AstraZeneca's total sales of Seroquel reached $4.87 billion last year.
• RESEaRCH
2008 were not eligible for appeal; all three expire in 2015. WARF says that it will appeal against the decision. See go.nature.com/ VdjqmA for more.
Boston, Massachusetts, plans to install 130 turbines off the coast of Cape Cod in Massachusetts, which will generate a maximum capacity of 468 megawatts. Opponents are vowing to fight the project in the courts.
